162
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Patients' views of treatment: methadone vs. buprenorphine

, , , , &
Pages 365-373 | Published online: 12 Jul 2009
 

Abstract

Introduction: Buprenorphine is being used increasingly as an alternative treatment to methadone in the treatment of heroin misuse.

Aim: We sought to obtain patients' views regarding the two medications and test the hypothesis that buprenorphine has a better reputation and is therefore preferred by patients.

Method: Patients receiving treatment in Cornwall, UK were asked to complete a 34‐item questionnaire.

Results: One‐hundred‐and‐thirty‐five questionnaires were returned. Methadone was considered superior in the domain relating to mental health, but buprenorphine was judged as better in other domains. The ease with which buprenorphine is diverted was highlighted. Overall, methadone was preferred, so refuting our hypothesis, but the differences were marginal.

Discussion: Patient preference alone does not justify the increased of cost of buprenorphine. However, for the sake of increasing patient choice it would seem important that it is available.

Acknowledgements

The authors would like to thank staff and patients of Cornwall Drug and Alcohol Team, particularly Ali Owen and John Skinner, who coordinated the questionnaire collection. The study was internally funded.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.